U.S. Agricultural Biotechnology Market - Databook 2025 to 2034

The U.S. agricultural biotechnology market size was estimated at USD 41.96 billion in 2024 and is projected to be worth around USD 98.3 billion by 2034, growing at a CAGR of 8.97% from 2025 to 2034.

Highlights of the U.S. Agricultural Biotechnology Market

• By application, the transgenic crops & animals segment held a dominant presence in the market in 2024.
• By application, the vaccine development segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By organism type, the plants segment accounted for a considerable share of the market in 2024.
• By organism type, the animals segment is projected to experience the highest growth rate in the market between 2025 and 2034.
• By type, the hybrid seeds segment led the U.S. agricultural biotechnology market.
• By type, the bio-pesticides segment is set to experience the fastest rate of market growth from 2025 to 2034.
• By technology, the genetic engineering segment registered its dominance over the market in 2024.
• By technology, the molecular diagnostics segment is anticipated to grow with the highest CAGR in the market during the studied years.

Industry Valuation and Growth Rate Projection

The term agricultural biotechnology is defined as the utilization of scientific approaches and instruments to change living organisms, specifically animals and plants, for agricultural manufacturing. This field brings together numerous different fields, including molecular biology, genetics, bioinformatics, and genomics, to grow crops and livestock that retain the features that are wanted. These characteristics may include a growth in production, an enhancement in nutritional value, tolerance to environmental challenges like drought or salinity, resistance to pests and diseases, and enhanced post-harvest characteristics.

Market Trends

• The U.S. agricultural biotechnology market is highly influenced by the adoption of genetically modified crops, particularly in areas that often deal with drought and pests.
• The animal sector has seen a lot of growth in the past year due to demand and advances in recombinant protein manufacturing and other applications.
• A well-regulated framework in American agriculture and large levels of investment in research and development by both public and private sectors are driving advancements in crop biotechnology.

Restraints

• Research and commercialization of genetically modified crops requires extensive safety evaluations and acceptance from international and governmental bodies, which can be a lengthy and expensive process.
• A shift toward organic foods and public backlash against GMOs can restrain the adoption and acceptance of biotech innovations.
• Use of genetically modified crops extensively also leads to evolutionary changes among pets, which gain resistance to existing seeds and fertilizers. This has led to constrains in effectiveness of biotechnologically modified crops, demanding continuous innovation.

Opportunities

• Technologies such as CRISPR provide several new avenues to enhance crop traits, increase yields, and generate disease-resistant varieties, contributing to more efficient and resilient agricultural systems.
• Biotechnology can lead to water conservation efforts by advancing drought-resistant crops and optimizing irrigation practices.
• Biotechnology is constantly being used to improve the nutritional value of crops, understand nutritional deficiencies, and enhance overall health.

Recent Developments in the U.S. Agricultural Biotechnology Market

• In February 2025, IXP established its first fund, IXP Lifesciences Catalyst Fund, to inoculate early-stage biotech startups. The fund target is to build a portfolio of 20-25 firms that understand gaps in services and products over pharmaceuticals, medical technology, biotechnology, agrotechnology, specialty chemicals, and nutraceuticals.